Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$1.52M Buy
44,488
+1,472
+3% +$52K 0.17% 133
2019
Q1
$1.54M Buy
43,016
+3,830
+10% +$130K 0.17% 127
2018
Q4
$1.26M Buy
39,186
+4,129
+12% +$132K 0.16% 142
2018
Q3
$1.09M Sell
35,057
-247
-0.7% -$7.6K 0.11% 175
2018
Q2
$1.07M Buy
35,304
+968
+3% +$27.7K 0.12% 174
2018
Q1
$955K Sell
34,336
-87
-0.3% -$2.35K 0.1% 183
2017
Q4
$967K Buy
34,423
+181
+0.5% +$5.2K 0.1% 178
2017
Q3
$920K Sell
34,242
-400
-1% -$10.7K 0.1% 174
2017
Q2
$891K Buy
34,642
+3,799
+12% +$96.7K 0.1% 190
2017
Q1
$791K Buy
30,843
+2,889
+10% +$73.6K 0.09% 189
2016
Q4
$707K Buy
27,954
+3,841
+16% +$91.1K 0.08% 195
2016
Q3
$573K Buy
24,113
+9,211
+62% +$231K 0.08% 195
2016
Q2
$387K Buy
+14,902
New +$369K 0.05% 244
2014
Q3
Sell
-10,980
Closed -$286K 298
2014
Q2
$286K Sell
10,980
-5,586
-34% -$142K 0.05% 249
2014
Q1
$396K Buy
16,566
+45
+0.3% +$947 0.07% 212
2013
Q4
$323K Sell
16,521
-1,852
-10% -$37.3K 0.06% 242
2013
Q3
$389K Sell
18,373
-20,947
-53% -$458K 0.08% 212
2013
Q2
$866K Buy
+39,320
New +$954K 0.17% 130

Other funds holding EXC

Chemical Bank's EXC Position: Q2 2019 in Review

Chemical Bank increased its Exelon (EXC) stake by 3.4% in Q2 2019, buying an estimated $52K and bringing the position to 44,488 shares worth $1.52M. The position accounts for 0.17% of the portfolio, ranked #133.

Chemical Bank first reported a position in EXC in Q2 2013 and has held it in 18 quarters since. The position peaked at $1.54M in Q1 2019. 1,003 funds tracked by Wall St. Rank hold EXC as of Q2 2019.

  • Chemical Bank held 44,488 shares of Exelon worth $1.52M as of Q2 2019.
  • Chemical Bank bought 1,472 Exelon shares in Q2 2019, an estimated $52K.
  • Exelon made up 0.17% of Chemical Bank's portfolio in Q2 2019, its #133 holding.
  • Chemical Bank first reported a position in Exelon in Q2 2013 and has held it in 18 quarters since.
  • Chemical Bank's Exelon position peaked at $1.54M in Q1 2019.
  • 1,003 funds tracked by Wall St. Rank held Exelon as of Q2 2019.

Based on Chemical Bank's 13F filing for Q2 2019, filed 25 Jul 2019.